MedTrace Logo

Complete vs Culprit-only Revascularization to Treat Multi-vessel Disease After Early PCI for STEMI

NCT01740479 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4042

Last updated 2021-02-09

No results posted yet for this study

Summary

To determine whether, on a background of optimal medical therapy, including ticagrelor, opening of all suitable narrowings or blockages found at the time of primary PCI for an acute heart attack is better than treating only the culprit lesion in patients with multi-vessel disease.

Conditions

Interventions

PROCEDURE

Complete Revascularization Strategy

Staged PCI using second generation drug eluting stents (Promus Element Plus drug-eluting stent or newer version in this series is strongly recommended) of all suitable non-culprit lesions plus optimal medical therapy.

Sponsors & Collaborators

  • Population Health Research Institute

    lead OTHER

Principal Investigators

  • Shamir R Mehta, MD, MSc · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-01
Primary Completion
2019-06-07
Completion
2019-06-07

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01740479 on ClinicalTrials.gov